case_images: PMC8245233_01
case_images: Vital signs from IVC clamp until 90 minutes following MB administration. IVC, inferior vena cava; PV, portal vein; PR, postreperfusion; MB, methylene blue.
case_images: CRIA2021-6610754.001.jpg
case_images: PMC8245233_01_CRIA2021-6610754.001.jpg
case_images: fig1
case_images: As seen in Figure 1, her hemodynamics improved and no longer required escalating doses of vasoactive medications.  Figure 2shows that though she remained on vasopressin (0.04 units/min) and norepinephrine (8 mcg/min) when transferred to the ICU, her clinical picture improved.
case_images: Vasoactive medication use during case #1.
case_images: CRIA2021-6610754.002.jpg
case_images: PMC8245233_01_CRIA2021-6610754.002.jpg
case_images: fig2
case_images: As seen in Figure 1, her hemodynamics improved and no longer required escalating doses of vasoactive medications.  Figure 2shows that though she remained on vasopressin (0.04 units/min) and norepinephrine (8 mcg/min) when transferred to the ICU, her clinical picture improved.
case_images: PMC8245233_02
case_images: Vital signs from IVC clamp until 90 minutes following MB administration.
case_images: CRIA2021-6610754.003.jpg
case_images: PMC8245233_02_CRIA2021-6610754.003.jpg
case_images: fig3
case_images: Figures 3 and 4 show the effects of MB on her blood pressure and we were able to rapidly wean down her vasopressor requirements.
case_images: Vasoactive medication use during case #2.
case_images: CRIA2021-6610754.004.jpg
case_images: PMC8245233_02_CRIA2021-6610754.004.jpg
case_images: fig4
case_images: Figures 3 and 4 show the effects of MB on her blood pressure and we were able to rapidly wean down her vasopressor requirements.
case_images: PMC8245233_03
case_images: Vital signs from IVC clamp until 90 minutes following MB administration.
case_images: CRIA2021-6610754.005.jpg
case_images: PMC8245233_03_CRIA2021-6610754.005.jpg
case_images: fig5
case_images: This improved his hemodynamics quickly as noted in Figure 5.  Figure 6shows that 22 minutes after administration of MB, the norepinephrine infusion was discontinued.
case_images: Vasoactive medication use during case #3.
case_images: CRIA2021-6610754.006.jpg
case_images: PMC8245233_03_CRIA2021-6610754.006.jpg
case_images: fig6
case_images: This improved his hemodynamics quickly as noted in Figure 5.  Figure 6shows that 22 minutes after administration of MB, the norepinephrine infusion was discontinued.